Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial
Titel:
Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial
Auteur:
Halperin, Scott A Ye, Lingyun MacKinnon-Cameron, Donna Smith, Bruce Cahn, Pedro E Ruiz-Palacios, Guillermo M Ikram, Aamer Lanas, Fernando Lourdes Guerrero, M Muñoz Navarro, Sergio Raúl Sued, Omar Lioznov, Dmitry A Dzutseva, Vitalina Parveen, Ghazala Zhu, Fengcai Leppan, Laura Langley, Joanne M Barreto, Luis Gou, Jinbo Zhu, Tao